PRESS RELEASE published on 10/26/2023 at 10:27, 1 year ago EQS-Adhoc: paragon GmbH & Co. KGaA resolves bond buyback programme for up to nominal EUR 20,211,000.00 of its 6.75% bond 2017/2027
PRESS RELEASE published on 10/23/2023 at 07:30, 1 year ago paragon announces preliminary nine-month figures and raises earnings outlook for the full year
PRESS RELEASE published on 09/29/2023 at 15:56, 1 year 1 month ago paragon founder Klaus Dieter Frers is majority shareholder again
PRESS RELEASE published on 08/30/2023 at 08:00, 1 year 2 months ago paragon cooperates with Clarios, a global leader in low-voltage battery technologies
PRESS RELEASE published on 08/21/2023 at 07:30, 1 year 3 months ago paragon reports revenue success and significant debt reduction
PRESS RELEASE published on 05/12/2023 at 08:00, 1 year 6 months ago paragon with very strong start to the year - outlook confirmed
PRESS RELEASE published on 05/11/2023 at 10:54, 1 year 6 months ago EQS-Adhoc: paragon: Sale of AI subsidiary paragon semvox to CARIAD completed
PRESS RELEASE published on 04/25/2023 at 16:54, 1 year 6 months ago paragon to publish consolidated financial statements on May 22, 2023
PRESS RELEASE published on 02/06/2023 at 14:26, 1 year 9 months ago At paragon, the signs continue to point to growth
PRESS RELEASE published on 01/10/2023 at 07:31, 1 year 10 months ago EQS-Adhoc: paragon decides on a tender offer of up to CHF 10 million in relation to its outstanding CHF 21 million 4% bonds 2019-2023
Published on 11/21/2024 at 13:30, 34 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 34 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 1 hour 4 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 1 hour 4 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 1 hour 4 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 29 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 49 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 7 hours 6 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 44 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 19 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 19 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
